A recent collaborative study conducted by Fonterra, the University of Auckland, and the University of Otago has shed light on the potential stress-reducing benefits of supplementation with broad-spectrum phospholipids found in milk fat globule membranes (MFGM). This news was published in Nutritional Outlook.
The study, involving 122 healthy adults, spanned over a period of 12 weeks during which participants were randomly assigned to either receive daily doses of MFGM or a placebo. The results were assessed using The Depression, Anxiety, and Stress Scale (DASS-21) which revealed that individuals who received MFGM experienced significantly lower stress levels after both 6 and 12 weeks, in comparison to those in the placebo group.
Furthermore, the study indicated that a dosage of 600 mg of MFGM was linked to considerably reduced stress scores at both the 6-week and 12-week marks. On the other hand, a higher dosage of 1200 mg demonstrated lower stress scores only after 6 weeks. These findings provide compelling evidence supporting the potential use of milk-derived phospholipids as a means to promote overall well-being and effectively manage stress.
The implications of this research are significant, as it highlights the therapeutic potential of MFGM supplementation in combating stress. Further exploration in this area could potentially contribute to the development of innovative stress management strategies and open up new avenues for utilizing milk-derived phospholipids to enhance mental well-being.
